long
time
number
respiratori
infect
clinic
symptom
caus
respiratori
virus
detect
caus
agent
discoveri
human
metapneumoviru
bernadett
van
den
hoogen
colleagu
viru
discoveri
method
becom
focu
virologist
mark
increas
number
newli
detect
viral
pathogen
one
pathogen
human
bocaviru
hbov
initi
identifi
tobia
alland
respiratori
sampl
children
suffer
respiratori
tract
diseas
suspect
viral
origin
sinc
discoveri
hbov
numer
studi
relat
epidemiolog
pathogenesi
replic
newli
detect
viru
perform
provid
novel
insight
viral
infect
respiratori
tract
gastrointestin
diseas
base
sequenc
analys
isol
identifi
alland
cowork
hbov
group
famili
parvovirida
subfamili
parvovirina
genu
bocaviru
current
four
subtyp
identifi
frequent
detect
clinic
sampl
respiratori
tract
remain
isol
frequent
associ
gastrointestin
infect
symptom
hbov
genom
length
rang
nucleotid
plu
termin
sequenc
base
base
phylogenet
analys
electron
microscopi
analys
hbov
genom
clinic
specimen
genom
believ
consist
singlestrand
dna
neg
polar
neg
polar
confirm
realtim
nasba
termin
sequenc
assum
play
crucial
role
initi
viral
replic
parvovirida
famili
identifi
linker
sequenc
episom
genom
replic
intermedi
shown
high
homolog
termin
sequenc
minut
viru
canin
mvc
bovin
parvoviru
latter
provid
hint
zoonot
origin
hbov
either
decad
centuri
ago
recent
zhao
colleagu
show
genom
hbov
subtyp
circular
circular
natur
genom
rais
question
hairpin
structur
differ
hbov
subtyp
determin
whether
linker
structur
cellular
origin
date
genom
replic
hbov
assum
occur
manner
genom
replic
anim
parvoviru
via
roll
hairpin
mechan
would
gener
headtohead
tailtotail
intermedi
recent
detect
headtotail
sequenc
fit
replic
model
novel
cell
cultur
system
base
nuli
cufi
cell
immort
cell
line
abil
differenti
interfac
cultur
could
appropri
model
studi
question
regard
hbov
replic
recent
publish
cell
cultur
model
abl
support
hbov
replic
produc
classic
replic
form
parvovirus
moreov
shown
fulllength
genom
clone
plasmid
vector
abl
produc
infecti
particl
stabl
cell
transfect
plasmid
appear
like
hbov
either
persist
use
addit
altern
mechan
replic
remain
matter
specul
altern
replic
model
could
helper
virusdepend
initi
roll
circl
replic
recent
case
report
identifi
herpesviru
coinfect
hbovinfect
patient
surprisingli
cidofovir
therapi
viremia
decreas
hbov
elimin
even
though
patient
underli
immunodefici
could
produc
neutral
antibodi
consid
herpesvirus
abl
initi
roll
circl
replic
replic
character
headtotail
sequenc
ci
tran
given
anoth
subfamili
parvovirus
dependovirus
replic
exclus
presenc
helper
virus
herpesvirus
replic
model
worth
discuss
investig
viral
transcriptom
analyz
studi
reveal
rna
protein
put
orfx
protein
protein
like
transcrib
genom
organ
typic
member
bocaviru
genu
viral
genom
contain
least
three
open
read
frame
orf
although
experiment
verifi
encod
gene
wide
assum
like
protein
encod
hbov
genom
similar
function
protein
better
character
member
bocaviru
genu
thu
first
orf
end
like
encod
nonstructur
protein
known
wherea
subsequ
orf
like
encod
second
nonstructur
protein
believ
uniqu
bocavirus
third
orf
encod
protein
current
littl
inform
interact
hbov
protein
cellular
protein
primarili
secondari
reagent
hbov
proteinspecif
antibodi
versatil
cell
cultur
system
avail
materi
necessari
investig
interact
novel
revers
genet
system
publish
huang
colleagu
could
use
tool
analysi
function
hbov
protein
overexpress
protein
abl
form
capsidlik
structur
strongli
resembl
viral
particl
particl
use
analyz
th
cell
immun
evalu
hbovspecif
tcell
prolifer
tcell
isol
healthi
adult
contrast
parvoviru
hbov
induc
less
diverg
th
respons
respect
prolifer
interferon
gamma
product
protein
shown
immunomodulatori
effect
use
cell
cultur
approach
nearli
fulllength
clone
hbov
zhang
colleagu
shown
abl
indirectli
block
promot
thu
inhibit
product
interferon
beta
hbov
major
pathogen
detect
respiratori
gastrointestin
infect
date
four
subtyp
identifi
found
worldwid
without
region
geograph
border
restrict
follow
initi
discoveri
sweden
hbov
detect
europ
north
south
america
africa
asia
australia
four
distinct
subtyp
name
subtyp
mainli
associ
respiratori
diseas
also
found
stool
sampl
patient
suffer
diarrhea
preval
symptomat
patient
approxim
approxim
appear
hbov
high
frequenc
recombin
among
subtyp
deriv
recombin
two
other
novel
variant
seem
occur
frequent
initi
assum
seropreval
hbov
strongli
depend
age
investig
patient
cohort
rang
children
month
age
virtual
children
older
two
year
averag
children
adult
seropreval
lowest
follow
recent
clinic
studi
respiratori
infect
use
novel
multiplex
assay
shown
sever
infect
ie
infect
clinic
relev
requir
hospit
receiv
proper
laboratori
diagnosi
frequent
repres
coinfect
six
differ
pathogen
singl
patient
rang
coinfect
precis
rate
codetect
pathogen
occur
simultan
hbov
vice
versa
rang
high
rate
explain
fact
hbov
shed
asymptomat
patient
abl
persist
could
also
result
better
studi
design
last
sever
year
becom
imposs
publish
studi
respiratori
virus
without
screen
virus
known
time
studi
requir
one
reason
aforement
studi
use
multiplex
technolog
reveal
mark
frequenc
doubl
multipl
infect
independ
pathogen
investig
therefor
hbov
exclus
bystand
rather
studi
cohort
investig
past
mainli
hospit
patient
suffer
multipl
infect
frequent
previous
assum
contrast
virus
first
clinic
studi
present
hbov
codetect
addit
pathogen
respiratori
viru
fact
led
hypothesi
hbov
may
harmless
bystand
rather
true
pathogen
hypothesi
support
fact
imposs
fulfil
koch
postul
hbov
due
technic
restrict
ie
current
neither
versatil
cell
cultur
system
anim
model
establish
document
case
humantohuman
transmiss
hbov
current
limit
inform
pathogenesi
hbov
hbov
found
respiratori
tract
secret
stool
hbov
also
caus
viremia
ie
activ
replic
viru
detect
bloodserum
infect
patient
furthermor
hbov
found
duodenum
paranas
sinu
mucosa
intestin
biopsi
consid
organspecif
interfac
cell
cultur
hbov
particl
secret
apic
distal
ie
air
phase
liquid
phase
mimic
bloodstream
like
model
hbov
pathogen
model
analog
minut
viru
canin
viru
enter
host
via
respiratori
tract
reach
bloodstream
enter
gastrointestin
tract
via
bloodstream
ingest
final
viral
shed
take
place
via
either
cough
defec
model
pathogenesi
support
fact
seropreval
hbov
highest
respiratori
subtyp
wherea
less
frequent
less
seropreval
current
appear
age
group
affect
hbov
although
sever
infect
infect
requir
hospit
occur
primarili
patient
underli
diseas
sever
clinic
case
describ
children
adult
cancer
risk
group
current
specif
approv
treatment
hbov
infect
symptomat
treatment
may
requir
sever
case
analog
treatment
respiratori
tract
infect
date
singl
case
report
antivir
treatment
associ
elimin
hbov
patient
coinfect
hbov
boy
suffer
immunodefici
lost
abil
mount
antibodybas
immun
respons
treatment
cidofovir
specif
herpesvirus
viremia
decreas
hbov
infect
success
elimin
outcom
case
consist
outcom
anoth
clinic
case
observ
hbov
viremia
decreas
treatment
although
case
fatal
outcom
reason
must
also
mention
due
lack
anim
model
versatil
cell
cultur
system
develop
vaccin
extrem
difficult
therefor
result
effort
publish
prevent
method
hbov
infect
analog
respiratori
viru
infect
laboratori
research
viru
treat
manner
parvovirus
german
nation
committe
biolog
safeti
zentralkommiss
biologisch
sicherheit
zkb
consequ
classifi
viru
biosafeti
level
agent
due
lack
cell
cultur
system
diagnosi
hbov
infect
exclus
base
molecular
detect
method
laboratori
current
use
inhous
pcr
realtim
pcr
assay
target
gene
nucleic
acidbas
detect
method
diagnosi
hbov
describ
number
commerci
avail
approv
multiplex
assay
develop
brought
market
assay
also
detect
human
bocaviru
includ
luminex
rvp
assay
luminex
usa
respifind
assay
pathofind
netherland
appear
like
assay
detect
hbov
develop
although
mani
current
avail
assay
filmarray
idaho
diagnost
usa
respid
assay
luminex
usa
pathogen
neglect
note
laboratori
follow
fda
rule
import
keep
mind
luminex
rvp
xtag
fast
assay
receiv
fda
clearanc
wherea
assay
fda
approv
detect
human
bocaviru
correctli
diagnos
hbov
infect
necessari
screen
clinic
sampl
respiratori
tract
stool
sampl
depend
whether
primari
symptom
respiratori
gastrointestin
correspond
serum
sampl
latter
great
import
viremia
observ
activ
infect
wherea
hbov
shed
otherwis
healthi
patient
like
due
persist
infect
without
viremia
although
discov
sever
year
ago
still
question
answer
relat
human
bocaviru
despit
increas
overwhelm
amount
evid
viru
fact
pathogen
koch
modifi
postul
yet
fulfil
hbov
primarili
versatil
cell
cultur
system
anim
model
avail
moreov
viru
frequent
detect
copathogen
primarili
discoveri
hbov
new
era
clinic
studi
respiratori
infect
begun
studi
patient
screen
virtual
virus
known
time
studi
perform
current
primari
challeng
hbov
commun
develop
cell
cultur
system
anim
model
viru
propag
recent
publish
cell
cultur
system
use
cufi
nuli
cell
could
model
tool
prerequisit
search
answer
open
question
includ
question
regard
effect
antivir
disinfect
molecular
pathogenesi
hbov
tool
also
help
determin
whether
hbov
fact
seriou
pathogen
simpli
part
harmless
microbiom
host
base
current
avail
data
hbov
proven
harmless
bystand
recommend
hbov
treat
pathogen
thu
invers
presumpt
innoc
appli
hbov
one
tri
follow
histori
viru
discoveri
last
decad
perform
clinic
studi
field
respiratori
infect
obviou
increas
number
identifi
pathogen
rang
diagnost
tool
requir
clinic
studi
also
increas
thu
known
virus
diagnost
assay
demand
investig
clinician
peer
review
manuscript
describ
studi
thu
remain
unknown
whether
hbov
fact
pathogen
whether
codetect
rate
high
clinic
studi
hbov
infect
among
first
gener
studi
presenc
virtual
respiratori
pathogen
requir
assess
